EP 1207906 A1 20020529 - TREATMENT OF PATIENTS HAVING NON-HODGKINS LYMPHOMA WITH BONE MARROW INVOLVEMENT WITH ANTI-CD20 ANTIBODIES
Title (en)
TREATMENT OF PATIENTS HAVING NON-HODGKINS LYMPHOMA WITH BONE MARROW INVOLVEMENT WITH ANTI-CD20 ANTIBODIES
Title (de)
BEHANDLUNG VON NON-HODGKIN LYMPHOM PATIENTEN MIT KNOCHENMARK UNTER BETEILIGUNG VON ANTI-CD20 ANTIKÖRPERN
Title (fr)
TRAITEMENT POUR PATIENTS ATTEINT D'UN LYMPHOME DIFFERENT DE LA MALADIE DE HODGKINS ET QUI TOUCHE LA MOELLE OSSEUSE, AVEC DES ANTICORPS ANTI-CD20
Publication
Application
Priority
- US 0040459 W 20000725
- US 14828799 P 19990811
Abstract (en)
[origin: WO0110462A1] This invention relates to methods of reducing bone marrow involvement in B cell lymphoma patients prior to radioimmunotherapy by administering monoclonal antibodies which target cancerous B cells.
IPC 1-7
IPC 8 full level
A61K 51/00 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61K 39/39558 (2013.01); A61P 35/00 (2017.12); C07K 16/2887 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0110462 A1 20010215; AU 7626000 A 20010305; AU 784971 B2 20060810; CA 2378646 A1 20010215; CN 100389825 C 20080528; CN 101259270 A 20080910; CN 1373671 A 20021009; EP 1207906 A1 20020529; EP 1207906 A4 20050706; HK 1048945 A1 20030425; JP 2003513012 A 20030408; MX PA02001398 A 20020812; MY 136635 A 20081128; NO 20020639 D0 20020208; NO 20020639 L 20020411; TW I279233 B 20070421
DOCDB simple family (application)
US 0040459 W 20000725; AU 7626000 A 20000725; CA 2378646 A 20000725; CN 00811664 A 20000725; CN 200810092138 A 20000725; EP 00965561 A 20000725; HK 03101198 A 20030218; JP 2001514978 A 20000725; MX PA02001398 A 20000725; MY PI20003551 A 20000803; NO 20020639 A 20020208; TW 89116114 A 20000810